Name: Latest research reports of Cohance Lifesciences Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Cohance Lifesciences Ltd.
Rating: 5
Author: ICICI Securities Limited

Nifty 50

30 May 2025, 12:00AM

24750.70

-0.33%

Rollover Analysis

Nifty 50

SBI Securities

During the May series, Nifty futures remained confined within a narrow range of just 1165 points, which was the tightest in recent memory, reflecting a phase of subdued volatility and indecisiveness among market participants. For the majority of the series, the index hovered in a consolidation zone, with neither the bulls nor the bears asserting strong control. Despite the lack of a decisive trend, the index showed resilience and managed to close the series in green, indicating underlying strength.

Nifty 50 is trading at high day volume of 853.9M.

Bank Nifty

30 May 2025, 12:00AM

55749.70

0.37%

Daily Market Mirror

Bank Nifty

SBI Securities

End of Day Summary

Bank Nifty is trading above all available SMAs

Aditya Birla Fashion and Retail Ltd.

29 May 2025, 12:00AM

85.85

-1.89%

BP Equities Q4FY25 Result Update Aditya Birla Fashion & Retail Ltd.

Results Update: Aditya Birla Fashion and R...

BP Wealth

...

Aditya Birla Fashion and Retail Ltd. is trading below all available SMAs

Banks

SECTOR | 29 May 2025, 12:00AM

BP Equities Banking Review Q4FY25

Banks

BP Wealth

BP Wealth released a Sector Update report for Banks on 29 May, 2025.

Cohance Lifesciences Ltd.

29 May 2025, 12:00AM

1047.70

-1.76%

Building drivers to rise up the value chain

Buy: Cohance Lifesciences Ltd.

Target

ICICI Securities Limited

Cohance Lifesciences’ (Cohance) Q4FY25 pro forma financial performance was below our expectation. Momentum across its pharma CDMO (+31% YoY) was strong, while specialty chemical CDMO business growth (+75%) is beginning to recover.

Number of FII/FPI investors increased from 201 to 218 in Mar 2025 qtr.

Nifty 50

29 May 2025, 12:00AM

24750.70

-0.33%

Sectoral Derivative Snapshot

Nifty 50

SBI Securities

Retail Research

SBI Securities released a Strategy Note report for Nifty 50 on 30 May, 2025.

Bank Nifty

29 May 2025, 12:00AM

55749.70

0.37%

Sectoral Technical Snapshot

Bank Nifty

SBI Securities

Retail Research

Bank Nifty is trading above all available SMAs

Britannia Industries Ltd.

29 May 2025, 12:00AM

5510.50

0.27%

BRITANIA INDUSTRIES LTD

Buy: Britannia Industries Ltd.

Target

Geojit BNP Paribas

Britannia delivered a strong quarter, with growth in the topline, on the back of an expanded network, effective cost management and margin preservation despite significant input inflation. The management remained vigilant on input costs and competition, executing a disciplined return on investment-focused strategy for organic as well as inorganic growth. In fact, although input costs remain a concern, the company's disciplined approach, commitment towards sustainability as well as...

Number of FII/FPI investors decreased from 931 to 885 in Mar 2025 qtr

Indian Hotels Company Ltd.

29 May 2025, 12:00AM

769.85

0.98%

INDIAN HOTELS COMPANY LIMITED

Accumulate: Indian Hotels Company Ltd.

Target

Geojit BNP Paribas

*over or under performance to benchmark index Founded in 1902, Indian Hotels Company Ltd. (IHCL) is a leading hospitality player with a portfolio of 381 hotels across 14 countries. It owns popular brands like Taj,...

Indian Hotels Company Ltd. is trading below its 30 day SMA of 780.5

Tata Chemicals Ltd.

29 May 2025, 12:00AM

887.15

-0.45%

TATA CHEMICALS

Hold: Tata Chemicals Ltd.

Recommendation Target

Geojit BNP Paribas

TCL faces short-term challenges, including sluggish demand in the US and Europe and decreasing export prices in the US market, as well as downward pressure on *over or under performance to benchmark index margins due to declining soda ash prices. However, the company is well-positioned for growth, driven by its strategic emphasis on speciality products and capacity expansion plans. A recovery in volumes and margins is anticipated in the next fiscal year, led by the Indian and Kenyan markets. The UK business is expected to show signs of improvement from the second quarter, driven by its new pharmaceutical...

Tata Chemicals Ltd. is trading below its 150 day SMA of 947.4